rs747285667
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001039213.4(CEACAM16):c.970G>A(p.Val324Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000622 in 1,560,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001039213.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM16 | NM_001039213.4 | c.970G>A | p.Val324Met | missense_variant | Exon 6 of 7 | ENST00000587331.7 | NP_001034302.2 | |
CEACAM16 | XM_017026795.2 | c.970G>A | p.Val324Met | missense_variant | Exon 5 of 5 | XP_016882284.1 | ||
CEACAM16-AS1 | NR_186815.1 | n.348-8713C>T | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000453 AC: 10AN: 220608Hom.: 0 AF XY: 0.0000249 AC XY: 3AN XY: 120580
GnomAD4 exome AF: 0.0000660 AC: 93AN: 1408140Hom.: 0 Cov.: 29 AF XY: 0.0000534 AC XY: 37AN XY: 692486
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Val324Met var iant in CEACAM16 has not been previously reported in individuals with hearing lo ss. This variant has been identified in 4/45370 European chromosomes by the Exom e Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs74728566 7). The valine (Val) at position 324 is not conserved in mammals, with 1 primate (gibbon) having a methionine (Met) at this position. Additional computational p rediction tools do not provide strong support for or against an impact to the pr otein. In summary, while the clinical significance of the p.Val324Met variant is uncertain, the lack of evolutionarily conservation suggests that it is more lik ely to be benign. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 228515). This variant has not been reported in the literature in individuals affected with CEACAM16-related conditions. This variant is present in population databases (rs747285667, gnomAD 0.02%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 324 of the CEACAM16 protein (p.Val324Met). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at